Spread and evolution of blaKPC-plasmid between Serratia marcescens and Klebsiella pneumoniae
•During the treatment of ceftazidime-avibactam, blaKPC-2 mutated to blaKPC-44 and blaKPC-71 with resistance to ceftazidime-avibactam.•blaKPC-bearing plasmid transferred between Serratia marcescens and Klebsiella pneumoniae.•The evolution of blaKPC impacted the activity of Klebsiella pneumoniae carba...
Gespeichert in:
Veröffentlicht in: | International journal of antimicrobial agents 2024-05, Vol.63 (5), p.107149-107149, Article 107149 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •During the treatment of ceftazidime-avibactam, blaKPC-2 mutated to blaKPC-44 and blaKPC-71 with resistance to ceftazidime-avibactam.•blaKPC-bearing plasmid transferred between Serratia marcescens and Klebsiella pneumoniae.•The evolution of blaKPC impacted the activity of Klebsiella pneumoniae carbapenemase towards carbapenem and avibactam.•The evolution of blaKPC may destroyed the conjugation efficiency and stability of plasmids.
blaKPC-carrying Enterobacterales have post great challenges to global healthcare systems. In this study, we reported the evolution and spread of blaKPC between Serratia marcescens and Klebsiella pneumoniae.
Four S. marcescens and one K. pneumoniae strains were isolated from the sputum samples of the patient. Antimicrobial susceptibility tests and whole genome sequencing were performed to investigate the phenotype & genotype of strains. Conjugation assays, cloning experiment and kinetic parameters measuring were performed to explore the spread and antimicrobial resistance mechanisms.
The evolution and transmission of blaKPC-2 occurred during the treatment of ceftazidime-avibactam and trimethoprim-sulfamethoxazole. Analysis of the antimicrobial susceptibility and genetic profiles of the clinical strains showed that blaKPC-2 evolved into blaKPC-71 and blaKPC-44, together with resistance to ceftazidime-avibactam and carbapenems susceptibility recovery under antimicrobial pressure. Cloning and expression of blaKPC-44 & blaKPC-71 in E. coli DH5α showed that KPC-44 and KPC-71 resulted in a 64∼128-fold increase in the MIC value for ceftazidime-avibactam. Meanwhile, the kinetic assays also showed that the enzyme activity of KPC-44 and KPC-71 towards carbapenems was destroyed and couldn't be inhibited by avibactam. Based on the conjugation assay and whole genome sequence analyses, we provided evolutionary insights into the transmission pathway trace of blaKPC-bearing plasmids between S. marcescens and K. pneumoniae.
Mixed-species co-infection is one of the risk factors leading to the spread of plasmids carrying carbapenem-resistant genes, and increased surveillance of multidrug-resistant Enterobacterales is urgently needed.
[Display omitted] |
---|---|
ISSN: | 0924-8579 1872-7913 |
DOI: | 10.1016/j.ijantimicag.2024.107149 |